$LCDX Caliber Imaging & Diagnostics Appoints Steven M.

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
$LCDX Caliber Imaging & Diagnostics Appoints Steven M. Ridge and Ben J. Alexander as Regional Sales Managers for West and Midwest


Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., has appointed Steven M. Ridge as Midwestern Regional Sales Manager and Ben J. Alexander as Western Regional Sales Manager, both newly created positions. Each will be focused on further developing the Company's sales initiatives for its VivaScope® platform in the West and Midwest regions of the United States. The FDA-cleared VivaScope® devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties.
L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "As a part of our ongoing efforts to expand Caliber I.D.'s footprint within the U.S. healthcare market, it is imperative that we bolster the Company's regional sales initiatives and increase our sales force. I am very pleased that Steven Ridge and Ben Alexander, both industry veterans, have agreed to join our team to oversee our sales efforts in the West and Midwest. Steve and Ben's experience make them ideal candidates to sell into a market consisting of physicians; pharmaceutical, cosmeceutical and skincare product development companies; government agencies; academic institutions; and anyone doing research on skin at the cellular level."

Mr. Ridge has more than 30 years of biomedical sales experience. He most recently served as Bioscience Sales Specialist-Midwest Region at Nikon Instruments Inc. Prior to this, he was VP of Marketing for three divisions within Roper Industries' Imaging Group, where he produced $10M in new sales by introducing globally nine new products to market in two years. Earlier, he held various sales and marketing positions at a series of companies including Fryer Company Inc. and Leica Microsystems Inc. He holds a BS degree from Iowa State University.

Mr. Alexander has nearly 30 years experience in sales and biomedical research. He most recently served as Technical Microscopy Specialist at McBain Systems/Leica Microsystems, where he represented the companies' industrial, forensic and educational accounts in Southern California. Among his accomplishments, he increased territory sales by 20 percent in 2012. Prior to this, he served as Western Territory Manager at Biolog, Inc. Earlier, he held sales positions at Thermo Electron Corp. (now ThermoFisher) and ISC BioExpress. He holds a BS degree from the University of Texas at Austin.

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. The FDA-cleared VivaScope® devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy while also having potential applications in several other medical and research specialties. VivaScope® is a registered trademark of Caliber Imaging & Diagnostics. For more information about Caliber I.D. and its products, please visit www.caliberid.com.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

CONTACT: Richard Pulsifer
Chief Financial Officer
(617) 348-9821

Investor Relations:
Dian Griesel Int'l.
Cheryl Schneider
(212) 825-3210

Public Relations:
Dian Griesel Int'l.
Susan Forman or Laura Radocaj
(212) 825-3210
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 146

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 177

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 312

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 210

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 145

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 233

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading

Top 5 Most Recently Viewed Articles

West Pharmaceuticals Welcomes Janet Haugen to Its Board

Updated Category News Views 225

West Pharmaceuticals Welcomes a New Board Member West Pharmaceutical Services, Inc. (NYSE: WST), a leader in the field of innovative injectable drug solutions, has announced an exciting change to its leadership. The company has welcomed Janet Haugen as the newest addition to its Board of Directors, bringing the board's total to twelve members. This strategic move is...

Continue Reading
Middlefield Banc Corp Declares Effective Dividend Strategy

Updated Category News Views 142

Middlefield Banc Corp Cash Dividend Announcement Middlefield Banc Corp. (NASDAQ: MBCN) recently revealed an important update about its dividends, a topic that resonates significantly with both current and potential investors. In a recent board meeting, the executives declared a quarterly cash dividend of $0.21 per common share, indicative of the corporation's ongoing...

Continue Reading
JELD-WEN Announces Major Asset Sale to Enhance Growth Strategy

Updated Category News Views 168

JELD-WEN Completes Significant Divestiture for Future Growth JELD-WEN Holding, Inc. (NYSE: JELD) has made a crucial decision regarding its Towanda facility as part of a court-directed divestiture. This strategic shift involves entering into an asset purchase agreement with Woodgrain Inc. for the Towanda business and its assets. The sale amounts to approximately $115...

Continue Reading
Royal Caribbean Group Announces Significant Dividend Increase

Updated Category News Views 134

Royal Caribbean Group Boosts Dividend Significantly Royal Caribbean Group (NYSE: RCL) recently announced an impressive increase in its quarterly dividend, demonstrating the company's ongoing commitment to its shareholders. The Board of Directors has declared a payment of $1.50 per common share, marking a notable 50% boost. Shareholders will see this payment on April 3,...

Continue Reading
Scholarship Opportunity for Aspiring Entrepreneurs Nationwide

Updated Category News Views 161

Andrew Hillman Launches Scholarship for Entrepreneurs Future business leaders across the United States now have a valuable opportunity to secure financial assistance through the Andrew Hillman Scholarship for Entrepreneurs. This esteemed initiative aims to support aspiring entrepreneurs committed to making a mark in the business world. Founded by Andrew Hillman, a...

Continue Reading